Head and Neck Cancer CDX Models

Explore Head and Neck Cancer CDX Models:

Model NameDescription
Cal 27The Cal 27 xenograft model is derived from human oral squamous cell carcinoma and is used to study aggressive head and neck cancers and test anticancer therapies.
RPMI2650The RPMI2650 xenograft model is derived from human nasal septum carcinoma and is used to investigate upper respiratory tract tumors and evaluate treatment responses.
Detroit 562The Detroit 562 xenograft model is derived from human pharyngeal carcinoma and is used to study head and neck cancers and assess therapeutic efficacy.
HSC-2The HSC-2 xenograft model is derived from human oral squamous cell carcinoma and is used to evaluate tumor growth and response to anticancer agents.